Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IARA: Creatine for Chemotherapy-Related Cognitive Decline in Early-Stage Breast Cancer
NCT07372144Phase 3Not yet recruiting
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Aug 2026
- Primary completion
- Jun 2028
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of creatine in chemotherapy-induced cognitive impairment (CICI), sponsored by Instituto D’Or de Pesquisa e Ensino. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
creatine
03
Conditions
chemotherapy-induced cognitive impairment (CICI)
Beyond the preview
Go deeper on NCT07372144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07372144.